By Prof Phil Thompson, Respiratory Physician, Nedlands
Airway diseases including asthma, chronic bronchitis, bronchiectasis and rhinosinusitis are complex.
They have a variety of subsets, can co-exist, and are often confused with each other, creating challenges for patients and doctors alike.
This has encouraged a treatment paradigm focussing on treating key pathological features of a patient’s disease. The evolution of monoclonal antibodies targeting specific mediators and impacting cell function have encouraged this....
Airway diseases including asthma, chronic bronchitis, bronchiectasis and rhinosinusitis are complex.
They have a variety of subsets, can co-exist, and are often confused with each other, creating challenges for patients and doctors alike.
This has encouraged a treatment paradigm focussing on treating key pathological features of a patient’s disease. The evolution of monoclonal antibodies targeting specific mediators and impacting cell function have encouraged this....
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.